Pfizer Ltd - 500680 - Closure of Trading Window
We would like to inform you that, for the purpose of declaration of financial results of the Company, for the quarter and half year ended September 30, 2021, the trading window of the Company shall remain closed from Thursday, September 30, 2021 (close of business) till 48 hours after the results are made public.
Am I fully vaccinated without a coronavirus vaccine booster?
Am I fully vaccinated without a COVID-19 vaccine booster? Yes, people who got a two-dose vaccine or the single-dose Johnson & Johnson shot are considered fully vaccinated even without a booster. The U.S. Centers for Disease Control and Prevention says you're fully vaccinated two weeks after receiving a second dose of the Pfizer or Moderna vaccine, or one dose of the J&J. The vaccines offer strong protection against serious illness. But U.S. health officials now recommend boosters for some people at higher risk for severe illness from COVID-19 based on evidence that protection against milder disease can wane, especially among older adults. The CDC says people 65 and older, long-term care residents and others ages 50 to 64 with health problems such as diabetes or heart disease should get boosters if they got Pfizer shots at least six months ago. The agency stopped short of recommending boosters for people 18 to 49 with health problems, but says they can also get the shot after .
Pfizer Covid-19 vaccine for kids may not be available until November
Pfizer has submitted research to the U.S Food and Drug Administration on the effectiveness of its COVID-19 vaccine in children but the shots may not be available until November
Biden touts Pfizer booster access after CDC boss overrules panel
The Centers for Disease Control and Prevention director, Rochelle Walensky, issued a statement advising that booster shots could be given to people with the Pfizer vaccine 6 months after second shot
US FDA okays Covid booster shot for people above 65, or at high-risk
The US Food and Drug Administration (FDA) has authorised booster shots of the Pfizer Covid-19 vaccine for people aged 65 and older or at high-risk
Indexes close up more than 1% as investors assess Fed news
Upbeat outlooks from Accenture and Salesforce helped to bolster the market, while the U.S. Food and Drug Administration late Wednesday authorized a booster dose of the Pfizer-BioNTech COVID-19 vaccine for those 65 and older.
COVID-19: India to not buy Pfizer, Moderna vaccines as domestic output jumps
The Indian government has also declined to meet the U.S. companies' requests for legal protection over any side-effects from the use of their shots, two of the sources said. Pfizer Covid-19 vaccine safely bolsters antibodies in younger kids
Drugmaker, partner BioNTech to submit data to US regulators
US FDA panel backs booster shot for elderly, high risk groups
A US FDA advisory panel has endorsed a booster shot of Pfizer-BioNTech Covid-19 vaccine six months after full inoculation in people above 65 years and for individuals at high risk for severe disease Pfizer Ltd - 500680 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39 (3) and other application regulations of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Registrar and Transfer Agent of the Company, KFin Technologies Private Limited has received request for issue of duplicate Share Certificate(s) from the Shareholders.